| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012450103 |
| P356 | DOI | 10.1038/CR.2015.20 |
| P932 | PMC publication ID | 4349249 |
| P698 | PubMed publication ID | 25675982 |
| P5875 | ResearchGate publication ID | 272187232 |
| P50 | author | Chaowei Fu | Q54357957 |
| Nidan Qiao | Q59545034 | ||
| P2093 | author name string | Yin Wang | |
| Hong Chen | |||
| Tao Wang | |||
| Juan Zhou | |||
| Yi Zhang | |||
| Jie Zheng | |||
| Ying Mao | |||
| Hong Peng | |||
| Shan Huang | |||
| Zhi-Qiang Li | |||
| Yao Zhao | |||
| Yong-Fei Wang | |||
| Qing-Zhong Wang | |||
| Zhao Ye | |||
| Li Pan | |||
| Shi-Qi Li | |||
| Ming Shen | |||
| Yong-Yong Shi | |||
| Liang-Fu Zhou | |||
| Jian-Hua Chen | |||
| Ying-Chao Liu | |||
| Rong-Gui Hu | |||
| Jue Ji | |||
| Dai-Zhan Zhou | |||
| Dao-Ying Geng | |||
| Wei-Min Bao | |||
| Yi-Ming Li | |||
| Rong Xie | |||
| Qi-Lin Zhang | |||
| Wei-Jun Tang | |||
| Qi-Sheng Tang | |||
| Yi-Chao Zhang | |||
| Jia-Wei Shen | |||
| Wen-Qiang He | |||
| Chuan-Xin Huang | |||
| Zhao-Yun Zhang | |||
| Zhi-Feng Shi | |||
| Hong-Ying Ye | |||
| Hui-Jia Qiu | |||
| Xiao-Lan Qin | |||
| Xue-Fei Shou | |||
| Zeng-Yi Ma | |||
| Zhi-Jian Song | |||
| Zu-Jia Wen | |||
| P2860 | cites work | Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. | Q54694108 |
| Cushing's syndrome | Q56228192 | ||
| Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas | Q59095410 | ||
| P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease | Q81930434 | ||
| UBPY: a growth-regulated human ubiquitin isopeptidase. | Q24336064 | ||
| Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex | Q24621192 | ||
| Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement | Q24629410 | ||
| Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency | Q28242164 | ||
| Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes | Q28511379 | ||
| The structural basis for 14-3-3:phosphopeptide binding specificity | Q29547190 | ||
| USP8 promotes smoothened signaling by preventing its ubiquitination and changing its subcellular localization | Q34130136 | ||
| AIP mutation in pituitary adenomas in the 18th century and today | Q34157625 | ||
| Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings | Q34344241 | ||
| Syndromes of glucocorticoid resistance | Q34344481 | ||
| Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). | Q34381917 | ||
| The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. | Q34630270 | ||
| The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline | Q34760816 | ||
| The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy | Q34763495 | ||
| Activating mutations of the stimulatory G protein in the McCune-Albright syndrome | Q34981177 | ||
| Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. | Q35105992 | ||
| EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas | Q35578652 | ||
| USP8 is a novel target for overcoming gefitinib resistance in lung cancer | Q37476722 | ||
| Managing Cushing's disease: the state of the art. | Q38177740 | ||
| Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo | Q40142306 | ||
| Expression and function of sonic hedgehog pathway components in pituitary adenomas: evidence for a direct role in hormone secretion and cell proliferation | Q40373963 | ||
| Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. | Q41186916 | ||
| Mutations in the deubiquitinase gene USP8 cause Cushing's disease | Q41716700 | ||
| Clonal origin of pituitary adenomas | Q45035533 | ||
| Corticotroph adenoma of the pituitary in a patient with X-linked adrenal hypoplasia congenita due to a novel mutation of the DAX-1 gene | Q46630244 | ||
| Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors | Q48089950 | ||
| Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease | Q48415480 | ||
| A decade of pituitary microsurgery. The Herbert Olivecrona lecture | Q48537891 | ||
| Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease. | Q50471525 | ||
| Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. | Q50967404 | ||
| 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. | Q53532387 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | Cushing's disease | Q1947304 |
| P304 | page(s) | 306-317 | |
| P577 | publication date | 2015-02-13 | |
| P1433 | published in | Cell Research | Q1524018 |
| P1476 | title | Recurrent gain-of-function USP8 mutations in Cushing's disease | |
| P478 | volume | 25 |
| Q47558765 | A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. |
| Q57793628 | Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors |
| Q99545483 | Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor |
| Q63384377 | Breaking the chains: deubiquitylating enzyme specificity begets function |
| Q89196972 | CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis |
| Q58789954 | Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease |
| Q57470855 | Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas |
| Q35686067 | Cushing's disease: towards precision medicine |
| Q28262360 | Cushing's syndrome |
| Q37181996 | Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease. |
| Q48265884 | Deubiquitylating enzymes and drug discovery: emerging opportunities. |
| Q92920851 | Driver mutations in USP8 wild-type Cushing's disease |
| Q52738992 | EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis. |
| Q93127216 | Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis |
| Q35747250 | Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas |
| Q89510579 | Exploring the Role of Novel Medical Therapies for Aggressive Pituitary Tumors: A Review of the Literature-"Are We There Yet?" |
| Q91670265 | Expression of EGFR in Pituitary Corticotroph Adenomas and Its Relationship With Tumor Behavior |
| Q50060136 | Expression of MMP-9, PTTG, HMGA2, and Ki-67 in ACTH-secreting pituitary tumors and their association with tumor recurrence |
| Q58796556 | Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles |
| Q37204404 | Gene mutations in Cushing's disease |
| Q48100826 | Genetic mechanisms of human hypertension and their implications for blood pressure physiology. |
| Q53683262 | Genetics of Cushing's Syndrome. |
| Q48162581 | Genetics of Cushing's disease. |
| Q38553643 | Genetics of Cushing's disease: an update |
| Q90540463 | Genetics of Pituitary Tumours |
| Q49357332 | Genomic Alterations in Sporadic Pituitary Tumors |
| Q92512997 | Germline USP8 Mutation Associated With Pediatric Cushing Disease and Other Clinical Features: A New Syndrome |
| Q33622368 | Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma. |
| Q58793747 | Identification of recurrent USP48 and BRAF mutations in Cushing's disease |
| Q37228518 | Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells |
| Q39074161 | Integration of cellular ubiquitin and membrane traffic systems: focus on deubiquitylases |
| Q36231629 | Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas |
| Q41667684 | MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma |
| Q38687124 | Mechanisms of regulation and diversification of deubiquitylating enzyme function. |
| Q89965064 | Molecular Mechanisms of Glucocorticoid Resistance in Corticotropinomas: New Developments and Drug Targets |
| Q90580125 | Novel insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms |
| Q39190559 | Overview of the 2017 WHO Classification of Pituitary Tumors |
| Q36716025 | Pituitary Medicine From Discovery to Patient-Focused Outcomes |
| Q54961209 | Pituitary-Directed Therapies for Cushing's Disease. |
| Q90047343 | Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy |
| Q33632000 | Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations. |
| Q58694608 | Recent advances in understanding corticotroph pituitary tumor initiation and progression |
| Q52656860 | Role of the ubiquitin/proteasome system on ACTH turnover in rat corticotropes. |
| Q38777251 | Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside |
| Q89892586 | SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors |
| Q90505741 | Small molecules that target the ubiquitin system |
| Q38785782 | Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease |
| Q89032142 | Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma |
| Q99410781 | TMEM79/MATTRIN defines a pathway for Frizzled regulation and is required for Xenopus embryogenesis |
| Q64929342 | TSP-1 is downregulated and inversely correlates with miR-449c expression in Cushing's disease. |
| Q90589248 | Telomere length alterations and ATRX/DAXX loss in pituitary adenomas |
| Q45065674 | The 2017 World Health Organization classification of tumors of the pituitary gland: a summary |
| Q64268853 | The Epigenomics of Pituitary Adenoma |
| Q35813265 | The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease |
| Q92255633 | The Genetics of Pituitary Adenomas |
| Q55144847 | The Molecular Pathology of Cushing Disease: Are We Nearly There? |
| Q37400088 | The genome-wide mutational landscape of pituitary adenomas. |
| Q97539475 | The multiple roles of deubiquitinases in liver cancer |
| Q88294991 | The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43 |
| Q101476264 | Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors |
| Q52806299 | USP8 Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing. |
| Q43200816 | USP8 mutation in Cushing's disease |
| Q38545050 | USP8: a novel therapeutic target for Cushing's disease. |
| Q91679876 | Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing |
| Q92038158 | Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions |
| Q48120172 | What's new in pituitary pathology? |
Search more.